Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Research Article Volume 5 Issue 9

Kidney Manifestations in Chronic Hepatitis C

Sander BQ*, Veríssimo AR, Maiolini R, Maiolini CPTB, Siqueira RS, Tomazelli LJ, Rezende FA, Tinoco NB, Alvariz ES, Tosta Jr FV, Vidal MFP, Portela E, Neto e Silva GJT, Daghastanli AA, Fraga MG, Palma LGR, Coila WC, Daud BJDD, Nóbrega G, Silva M, Lobato ICCC, Povoa N, Gonçalves DM, Silva Neto FM, Dias MF, Rocha LVD, Espirito Santo BCC and Machado AEV

Professor of Gastroenterology of AproMed Consultant, Upper GI and Bariatric Endoscopy, Medical Director, Endoscopy Offices, Sander Medical Center - Day Hospital, Brazil

*Corresponding Author: Sander BQ, Professor of Gastroenterology of AproMed Consultant, Upper GI and Bariatric Endoscopy, Medical Director, Endoscopy Offices, Sander Medical Center - Day Hospital, Brazil.

Received: August 16, 2022; Published: August 19, 2022

Abstract

Introduction: Hepatitis C is a worldwide health problem. Between 1999 and 2017 there are 587,821 confirmed cases of viral hepatitis in Brazil with the following distribution: Hepatitis A: 164,892 (28.0%); Hepatitis B: 218,257 (37.1%); Hepatitis C: 200,839 (34.2%); Hepatitis D: 3,833 (0.7%). An association between hepatitis C virus (HCV) infection and mixed cryoglobulimeia in renal disease has been described with type I membranoproliferative glomerulonephritid being the most common renal impairment. Hepatitis C is a disease caused by the Hepatitis C virus, a flaviviridae RNA virus. HCV was identified by Choo and colleagues in 1989 in the United States. This condition is a major cause of liver-related morbidity, accounting for over 1 million deaths as a result of cirrhosis and hepatocarcinoma. It has a chronic and insidious character.

Objective: To report and discuss information from scientific articles that directly or indirectly treat renal manifestations in patients with chronic hepatitis c. 

Methods: A bibliographic search was performed in the Pubmed database using two different capture strategies, which involved the use of the “MeSH Database” tool applying in the search field the terms: " Hepatitis C " and " chronic Kidney disease " and the “Related Articles” tool. The articles captured by both strategies were considered for reading, as well as the articles cited in their bibliographic references.

Conclusions: After careful reading of the selected articles, it can be seen that the established and direct relationship between hepatitis C and chronic renal failure, particularly pseudomembranous glomerulonephrephritis due to cryoglobulin deposition. It was clear that chronic kidney disease, especially dialysis, is at increased risk for hepatitis C virus infection and, in addition, patients with chronic hepatitis C have as one of the extrahepatic manifestations the chronic kidney disease due to cryoglobulinemia.

 

Keywords: Hepatitis C; Chronic Kidney Disease (CKD); Membranoproliferative Glomerulonephritis (MPGN)

References

  1. Mesquita I., et al. “Renal pathology in HCV infected patients - Report of 148 patients and review of the literature”. Portuguese Journal of Nephrology and Hypertension 2 (2017): 91-99.
  2. Landino M., et al. “Hepatitis C infection in chronic kidney disease”. Division of nephrology and hypertension, University Miami Mille School of Medicine and the Miami Veterans Administration Hospital. Miami. Florida.
  3. Fabrizi F., et al. “Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis”. Digestive Diseases and Sciences 60 (2015): 3801-3813.
  4. Boletim epidemiológico. Secretaria de Vigilância em saúde - Ministério da Saúde 2018 - Brasil (2018).
  5. Davis GL., et al. “Projecting future complications of chronic hepatitis C in the United States”. Liver Transplantation 9 (2003): 331-338.
  6. Park H., et al. “A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection”. Journal of Viral Hepatitis 22 (2015): 897-905.
  7. Pawa S., et al. “Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease”. Clinical Gastroenterology and Hepatology 5 (2007): 1316-1320.
  8. Dalrymple LS., et al. “Hepatitis C virus infection and the prevalence of renal insufficiency”. Clinical Journal of the American Society of Nephrology 2 (2007): 715-721.
  9. Tang S and Lai KN. “Chronic viral hepatitis in hemodialysis patients”. Hemodialysis International 9 (2005): 169-179.
  10. Roth D., et al. Lancet 386 (2015): 1537-1545.
  11. Park H., et al. “Chronic Hepatitis C Virus (HCV) Increases the Risk of Chronic Kidney Disease (CKD) While Effective HCV Treatment Decreases the Incidence of CKD”. Hepatology (2017).
  12. Perico N., et al. “Hepatitis C infection and chronic renal diseases”. Clinical Journal of the American Society of Nephrology 4 (2009): 207-220.
  13. Chen Y-C., et al. “A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease”. Kidney International 85 (2014): 1200-1207.
  14. Bastiani M F., et al. “Prevalence of hepatitis C in patients with renal disease undergoing hemodialysis treatment”. Jornal Brasileiro de Patologia e Medicina Laboratorial 5 (2014): 327-331.
  15. Fabrizio Fabrizi., et al. “Hepatitis C and Its Metabolic Complications in Kidney Disease”. Annals of Hepatology 16 (2017): 851-861.
  16. Hsu C., et al. “Inter-feron-based therapy reduces risk of stroke in chronic hepa-titis C patients: a population based cohort study in Taiwan”. Alimentary Pharmacology and Therapeutics 38 (2013): 415-423.
  17. Noureddine L., et al. “Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis”. American Journal of Nephrology 32 (2010): 311-316.
  18. Tsui J., et al. “Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease”. Archives of Internal Medicine 167 (2007): 1271-1276.
  19. The complete KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Dis-ease is published simultaneously in Kidney International Supplements 8.3 (2018).
  20. Protocolo Clinico e Diretrizes Teraupeticas para hepatite C e Coinfecções. MINISTERIO DA SAUDE. Secretaria de Vigilancia em Saude Departamento de Vigilancia, Prevencao e Controle das Infeccoes Sexualmente Transmissiveis, do HIV/Aids e das Hepatites Virais. Brasilia (2019).

Citation

Citation: Sander BQ., et al. “Kidney Manifestations in Chronic Hepatitis C". Acta Scientific Gastrointestinal Disorders 5.9 (2022): 20-25.

Copyright

Copyright: © 2022 Sander BQ., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US